| Trial ID: | L5613 |
| Source ID: | NCT00317915
|
| Associated Drug: |
Irbesartan Treatment
|
| Title: |
Irbesartan in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Microalbuminuria|Hypertension
|
| Interventions: |
DRUG: Irbesartan treatment
|
| Outcome Measures: |
Primary: Development of overt nephropathy |
|
| Sponsor/Collaborators: |
Sponsor: Steno Diabetes Center Copenhagen | Collaborators: Bristol-Myers Squibb|Sanofi-Synthelabo
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2006-04-25
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00317915
|
